Summary of Study ST002115
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001340. The data can be accessed directly via it's Project DOI: 10.21228/M8HD8Q This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002115 |
| Study Title | LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells |
| Study Summary | HT1080 cells were treated with vehicle (DMSO), RSL3 (10 micromolar), ML210 (10 micromolar), or ML162 (10 micromolar) for 2 hours. Cellular metabolites were then extracted and analyzed by LC-MS. |
| Institute | University of Texas MD Anderson Cancer Center |
| Last Name | Gan |
| First Name | Boyi |
| Address | 6565 MD Anderson Blvd, Houston TX, 77030 |
| bgan@mdanderson.org | |
| Phone | 713-792-8653 |
| Submit Date | 2022-03-02 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzXML |
| Analysis Type Detail | LC-MS |
| Release Date | 2022-04-14 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR002243 |
| Treatment Summary: | Cells were seeded in 35-mm culture plates. When the cell confluence reached 70-80%, cells were treated with RSL3, ML210, or ML162 for 2 hours. |
